Mouse models for Type 1 Diabetes

Drug Discovery Today: Disease Models

Volumn 6, Issue 2, 2009, Pages 41-45

  Van Belle, T L ^a   Taylor, P ^a   von Herrath, M G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; VESICULAR MONOAMINE TRANSPORTER 2;

ALLOXAN DIABETES MELLITUS; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER MODEL; DIABETOGENESIS; DIAGNOSTIC IMAGING; DISEASE MODEL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTIC INFILTRATION; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; REVIEW; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

EID: 77949487898     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2009.03.008     Document Type: Review

References (40)

1. Ohashi P.S., et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65 (1991) 305-317
2. Oldstone M.B., et al. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65 (1991) 319-331
3. von Herrath M.G., et al. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1 (1994) 231-242
4. Martinic M.M., and von Herrath M.G. Real-time imaging of the pancreas during development of diabetes. Immunol. Rev. 221 (2008) 200-213
5. Shoda L.K., et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23 (2005) 115-126
6. Zhang L., et al. Insulin as an autoantigen in NOD/human diabetes. Curr. Opin. Immunol. 20 (2008) 111-118
7. Makino S., et al. Genetic analysis for insulitis in NOD mice. Jikken Dobutsu 34 (1985) 425-431
8. Ohsugi T., and Kurosawa T. Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. Lab. Anim. Sci. 44 (1994) 386-388
9. Wegmann D.R., and Eisenbarth G.S. It's insulin. J. Autoimmun. 15 (2000) 286-291
10. von Boehmer H., and Sarukhan A. GAD, a single autoantigen for diabetes. Science 284 (1999) 1135-1137
11. Haskins K., et al. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37 (1988) 1444-1448
12. Verdaguer J., et al. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186 (1997) 1663-1676
13. Lieberman S.M., et al. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173 (2004) 6727-6734
14. Wong F.S., et al. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183 (1996) 67-76
15. Tang Q., et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28 (2008) 687-697
16. Greeley S.A., et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8 (2002) 399-402
17. Kagohashi Y., et al. Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring. Diabetes 54 (2005) 2026-2031
18. Clough L.E., et al. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J. Immunol. 180 (2008) 5393-5401
19. Garza K.M., et al. Role of antigen-presenting cells in mediating tolerance and autoimmunity. J. Exp. Med. 191 (2000) 2021-2027
20. Lo D., et al. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol. 22 (1992) 1013-1022
21. Morgan D.J., et al. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157 (1996) 978-983
22. Gonzalez A., et al. Genetic control of diabetes progression. Immunity 7 (1997) 873-883
23. Luhder F., et al. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J. Exp. Med. 187 (1998) 379-387
24. Miller B.J., et al. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140 (1988) 52-58
25. Slattery R.M., and Miller J.F. Influence of T lymphocytes and major histocompatibility complex class II genes on diabetes susceptibility in the NOD mouse. Curr. Top. Microbiol. Immunol. 206 (1996) 51-66
26. Mora C., et al. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J. Immunol. 162 (1999) 4576-4588
27. Rohane P.W., et al. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44 (1995) 550-554
28. Haskins K., and McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249 (1990) 1433-1436
29. Katz J.D., et al. T helper cell subsets in insulin-dependent diabetes. Science 268 (1995) 1185-1188
30. Pakala S.V., et al. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186 (1997) 299-306
31. Stratmann T., et al. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 112 (2003) 902-914
32. Kyburz D., et al. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23 (1993) 1956-1962
33. Oxenius A., et al. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28 (1998) 390-400
34. Sarukhan A., et al. Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J. 17 (1998) 71-80
35. Roman L.M., et al. The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 61 (1990) 383-396
36. Pearson T., et al. Humanized SCID mouse models for biomedical research. Curr. Top. Microbiol. Immunol. 324 (2008) 25-51
37. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 (2008) 216-226
38. Saudek F., et al. Imaging the Beta-cell mass: why and how. Rev. Diab. Stud. 5 (2008) 6-12
39. Saisho Y., et al. Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J. Mol. Histol. 39 (2008) 543-551
40. Chatenoud L., and Bluestone J.A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7 (2007) 622-632